Compare PGEN & LCII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | LCII |
|---|---|---|
| Founded | 1998 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.5B |
| IPO Year | 2013 | 1994 |
| Metric | PGEN | LCII |
|---|---|---|
| Price | $6.86 | $100.77 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $8.33 | ★ $130.86 |
| AVG Volume (30 Days) | ★ 6.2M | 228.5K |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.91% |
| EPS Growth | N/A | ★ 35.18 |
| EPS | 0.03 | ★ 5.29 |
| Revenue | $230,981,000.00 | ★ $4,122,017,000.00 |
| Revenue This Year | $1,115.92 | $5.56 |
| Revenue Next Year | $81.04 | $4.25 |
| P/E Ratio | $231.00 | ★ $19.02 |
| Revenue Growth | N/A | ★ 10.18 |
| 52 Week Low | $2.99 | $84.33 |
| 52 Week High | $7.72 | $159.66 |
| Indicator | PGEN | LCII |
|---|---|---|
| Relative Strength Index (RSI) | 55.27 | 42.51 |
| Support Level | $3.96 | $89.00 |
| Resistance Level | $7.32 | $109.60 |
| Average True Range (ATR) | 0.39 | 2.67 |
| MACD | -0.07 | -0.61 |
| Stochastic Oscillator | 51.38 | 9.04 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
LCI Industries Inc supplies domestically and internationally components for the original equipment manufacturers of recreational vehicles and adjacent industries, including buses and trailers used to haul boats, livestock, equipment, and other cargo. It has two reportable segments: the original equipment manufacturers segment and the aftermarket segment. The OEM Segment manufactures or distributes components for the OEMs of RVs and adjacent industries, including buses; trailers used to haul boats, livestock, equipment, and other cargo; trucks; pontoon boats; trains; manufactured homes; and modular housing. Its products are sold to manufacturers of RVs such as Thor Industries, Forest River, Winnebago, and other RV OEMs, and to manufacturers in adjacent industries.